To test the hypothesis that congenital heart disease (CHD) in preterm infants with severe CHD (cyanotic or left-sided obstructive lesions, or congestive heart failure) is independently associated with necrotizing enterocolitis (NEC, stage II or greater). STUDY DESIGN: Single-institution retrospective birth cohort of preterm infants with gestational age 23 0/7 to 34 6/7 weeks delivered between 1 January 2002 and 31 December 2011, excluding infants who received comfort care. Patients were classified into severe CHD, mild CHD and control groups. RESULTS: Among 4678 infants, 170 (3.6%) had CHD and 118 (2.5%) developed NEC. The risk for NEC increased with severe CHD (adjusted relative risk (RR) = 3.72; 95% confidence interval (CI) = 1.37 to 10.10) but not with mild CHD (RR = 0.65; CI = 0.27 to 1.55). CONCLUSION: In this cohort, severe but not mild CHD was independently associated with increased risk for NEC. This finding, if confirmed by other studies, may help identify patients at risk for NEC.
INTRODUCTION
Necrotizing enterocolitis (NEC) is the most common gastrointestinal disease in neonates and causes considerable morbidity and mortality in premature infants. Premature infants are not the only infants at risk for developing NEC. In full-term neonates, a strong association has been reported between NEC and congenital heart disease (CHD). [1] [2] [3] [4] The pathophysiology of NEC in CHD includes intestinal hypoperfusion in patients with left-sided obstructive cardiac lesions because of episodes of inadequate cardiac output, shock and diastolic flow reversal in the abdominal aorta. 3, 5 In addition, a systemic inflammatory reaction may develop as a result of congestive heart failure (CHF) or cardiac surgery especially that with cardiopulmonary bypass. 1 A referral center reported that 201 preterm infants with CHD and a birth weight (BW) o2500 g, had a 1.7-fold increase in risk for NEC compared with other patients admitted to the neonatal intensive care unit (NICU). 6 This study only included univariate comparisons and no adjustment was made for important confounding variables such as gestational age (GA) or BW. McElhinney et al. showed an independent association between hypoplastic left heart syndrome or truncus arteriosus and NEC in a cohort study and found episodes of shock to be associated with NEC in a case-control subset. 2 In contrast, one study in 98 523 very low BW infants showed increased odds of NEC in infants with ventricular septal defect, atrial septal defect and ventricular septal defect with atrial septal defect. 7 The presence of CHF was not described in that study.
We sought to test the hypothesis that in preterm infants severe CHD, including lesions associated with cyanosis, left-sided obstruction or CHF is independently associated with NEC.
METHODS Design
This was a retrospective birth cohort study of preterm infants with GA 23 0/7 to 34 6/7 weeks delivered between 1 January 2002 and 31 December 2011 at the Parkland Memorial Hospital in Dallas, TX. During this 10-year period, there were no major related changes in practice, such as the introduction of donor breast milk or the establishment of a standardized feeding protocol. Data were collected prospectively in a NICU database by a research nurse (PJB) using pre-set definitions. The database provides information on 99.8% of eligible neonates, with high inter-rater reliability (o1% error). In addition, individual patient charts were reviewed for infants with NEC stage II or greater (modified Bell stage classification). 8 The study was approved by the Institutional Review Board at University of Texas Southwestern Medical Center and a waiver of consent was granted.
Study population
All preterm infants with GA 23 0/7 to 34 6/7 weeks born during the study period were included in the study except infants who received comfort care in the delivery room. The study population was limited to patients less than 35 weeks GA, who were admitted to the NICU, thereby providing an accurate assessment of risk factors for NEC. Infants were classified into three groups: (1) severe CHD, which included infants with lesions associated with cyanosis, left-sided obstructive lesions or CHF, (2) mild CHD such as septal defects and excluding infants in group 1 or (3) controls (all infants free of CHD). CHF was defined clinically by the treatment team by the presence of signs of CHF such as radiographic findings of cardiomegaly or pulmonary edema or the need for diuretic therapy. Infants with isolated patent ductus arteriosus (PDA) in the absence of CHD were included in the control group.
Variables
The primary outcome variable was proven NEC (stage II or greater, 8 with either unequivocal pneumatosis intestinalis on abdominal radiogram or characteristic findings of NEC observed at surgery or at autopsy); this definition excludes the diagnosis of spontaneous intestinal perforation. A secondary outcome variable, mortality to discharge, was defined as death before discharge from the hospital.
Variables collected from the NICU database included: GA, BW, sex, race/ ethnicity, multiple births, maternal pregnancy-induced hypertension, administration of betamethasome before delivery, 5-min Apgar score, umbilical artery catheterization, culture-proven sepsis (before the outcome of interest (NEC or death)), respiratory distress syndrome, type of cardiac lesion, CHF, administration of indomethacin for PDA, PDA ligation and postnatal age at the time of ligation. Patients were considered for indomethacin or ligation of their PDA if they did not have PDA-dependent CHD and developed CHF and clinical evidence of a large left to right shunt with at least four of these criteria: resting heart rate 4150 beats per min, hyperdynamic precordium, bounding pulses, characteristic murmur, cardiomegaly, shunt vasculature or abnormal echocardiogram (for example, increased left atrium/aorta ratio). 9 We also reviewed the medical record for all patients with NEC to collect information on age at NEC diagnosis, Bell Stage, type and caloric density of enteral feeds, episodes of culture-proven sepsis before NEC, days of antibiotics before NEC, blood transfusions in the 48-h preceding NEC, use of H2 blockers before NEC, episodes of low cardiac output before NEC (defined as episodes of hypotension with decreased systemic perfusion requiring presssors or hydrocortisone) and need for abdominal surgery.
Statistical analysis
Univariate analyses were done using χ 2 analysis (Pearson's χ 2 test using exact hypergeometric probability, followed if significant by Fisher's exact test for comparisons of two groups), Fisher's exact test, Mann-Whitney test, Student's t-test (adjusted if needed based on Levene's test for equality of variances), or analysis of variance followed by Dunnett C test. Adjusted relative risk (RR) was determined using robust Poisson regression in a generalized estimating equation model adjusted for GA, size for GA and variables that reached significance on univariate analysis. To avoid collinearity (that is, linear relationship between two explanatory variables, which might yield spurious results by increasing the standard error of the partial regression coefficients), BW was converted to BW z-score for GA and gender (using tables from Olsen et al.). 10 The most significant among related variables (for example, indomethacin for PDA versus PDA ligation) was selected for multivariate analysis. To assess whether the association between NEC and size for age was observed at all ranges of weight for GA, we performed a secondary multivariate analysis of NEC by BW quartiles (calculated using tables from Olsen et al.), 9 taking into account the same variables. To assess the association between NEC and septal defects, the frequency of NEC was analyzed by univariate and multivariate analysis in a subset of patients with septal defects and controls. Changes in mortality and frequency of NEC over time were analyzed using a control chart and statistical process control.
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Statistical analyses were performed by using SPSS version 21 (IBM SPSS Statistics, IBM Corporation, Armonk, NY, USA). P values o0.05 were considered statistically significant. Bonferroni correction was used for pairwise comparisons of proportions (controls versus patients with either severe or mild CHD). Statistical process control was performed using SPC for MS Excel (BPI Consulting, Cypress, TX, USA).
Sample size analysis
The study period was set to yield at least 100 patients with NEC. This would yield 10 patients per variable included in a multivariate analysis of the primary outcome using robust Poisson regression with 10 independent variables. All the other analyses should be considered as exploratory, especially those on medical review data, for which numbers were too small to exclude significance.
RESULTS

Neonatal characteristics
Among 4678 infants, 170 (3.6%) had CHD, including 130 mild CHD and 40 severe CHD (Figure 1 ). Classification of CHD lesions is shown in Table 1 . Table 2 shows the neonatal characteristics of the infants with mild CHD, severe CHD and controls. Infants with mild CHD had lower GA, BW, BW z-score and 5-min Apgar score, and had a higher percentage of RDS, umbilical artery catheters, treatment with indomethacin for PDA, PDA ligation and sepsis than controls. Infants with severe CHD had lower 5-min Apgar score and higher percentage of umbilical artery catheter, PDA ligation and sepsis than controls. Race/ethnicity, gender, antenatal steroids, pregnancy-induced hypertension and multiple births Figure 1 . Study population. CHD, congenital heart disease; GA, gestational age; NEC, necrotizing enterocolitis stage II or greater; wks, weeks.
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were not different among the three groups. Among patients who underwent PDA ligation, 64% received indomethacin.
Changes in mortality and NEC over time during the study period Yearly mortality and frequency of NEC did not significantly change during the study period ( Figure 2 ).
Necrotizing enterocolitis
On univariate analysis NEC in infants with severe CHD but not in those with mild CHD was significantly more frequent than in controls (Table 3) . Multivariate analysis was done using eight independent variables, which were all available in 4665 patients, including 118 with NEC. On multivariate analysis, the risk for NEC increased with severe CHD (adjusted RR = 3.72; 95% confidence interval (CI) = 1.37 to 10.10) but not with mild CHD (RR = 0.65; 95% CI = 0.27 to 1.55; Table 4 ). The risk for NEC decreased with increasing GA and BW z-score, and increased with indomethacin. The adjusted risk for NEC was lowest in the quartile with the highest BW. The adjusted risk for NEC was significantly higher in each of the other quartiles (Table 5 ).
In the subgroups of controls (n = 4508) and infants with septal defects (n = 102), the frequency of NEC was 2% among controls, 3% among infants with septal defect without CHF and 18% among those with septal defect with CHF (P = 0.025). On multivariate analysis, the risk for NEC increased in patients with septal defects with CHF (adjusted RR = 5.63; 95% CI = 1.45 to 21.88, P = 0.013) but not in those with septal defects without CHF (RR = 0.51; 95% CI = 0.16 to 1.63, P = 0.25). Exploratory analysis of risk factors and outcomes from chart review of patients with NEC is shown in Supplementary Tables 1  and 2 . Risk factors and outcomes were similar in patients with and without CHD. All cases of NEC in patients with CHD occurred before surgical repair.
Mortality
Mortality was higher in patients with severe CHD and those with mild CHD than in controls (Table 3) . On multivariate analysis the risk for mortality increased with severe CHD and mild CHD, decreased with increasing GA, BW z-score and 5-min Apgar score and decreased with administration of indomethacin for PDA (Table 4 ). The adjusted risk for death was lowest in the quartile with the highest BW and was significantly higher in two of the other quartiles (Table 5) .
DISCUSSION
The main finding of this study is that severe CHD, but not mild CHD, was an independent risk factor for NEC among preterm infants o 35 weeks GA. A similar finding was observed among patients with septal defects, in whom the adjusted risk of NEC increased only in those with CHF. Other factors increasing the risk of NEC included low GA or size for age and administration of indomethacin for PDA. All patients with CHD who developed NEC were also exposed to at least one other previously described risk factor for NEC. Factors contributing to NEC in infants with CHD and those without CHD were similar. CHD was an independent risk factor for mortality. Yearly mortality and frequency of NEC did not significantly change during the study period.
The results of our study are in agreement with several prior studies, which showed an increased frequency of NEC in preterm patients with severe CHD, especially with decreased organ perfusion. 2, 3, 5, 6, 12 McElhinney et al. described a cohort of 643 infants with CHD admitted to the cardiovascular intensive care unit in an attempt to identify factors associated with NEC in this population. By multivariate analysis, they showed an independent association between hypoplastic left heart syndrome or truncus arteriosus and NEC. They also performed a case-control study within their cohort, and after multivariate analysis found episodes of shock and younger GA, but not BW to be associated with NEC. 2 Dees et al. published a 23-year cohort of preterm infants with CHD and low BW transferred to a referral center. They found that NEC was significantly increased in these patients compared with the other patients admitted to the NICU. 6 More recently, in 2011, Natarajan described outcomes of infants admitted for severe CHD requiring surgical intervention during their initial admission. They compared late preterm (GA 34 to 36 6/7 weeks) with term infants and found an increase in the incidence of NEC in preterm infants compared with term infants with such CHD. 9 The study by Bain et al. involving a large database, showed an association between septal defects and NEC. 7 As the presence of CHF was not described in that study, we hypothesized that the adjusted risk of NEC in patients with septal defects would increase only in those with CHF; this is what was found in our study. Necrotizing enterocolitis in preterm infants C Motta et al Strengths of our study include a birth cohort design; the use of a prospective validated database thereby minimizing missing data, information bias and loss to follow-up; and the multivariate analysis including the degree of severity of CHD.
Limitations of our study include the retrospective and observational design. Therefore, our study only shows an association between CHD and NEC and CHD and mortality among preterm infants. The study was limited to infants o 35 weeks GA because the database only includes infants admitted to the NICU and all infants o 35 weeks are admitted to the NICU. The database does not include information about antenatal echography, reason(s) for preterm delivery or chorioamnionitis. This single-institution analysis yielded a small number of patients with NEC and CHD, even though sample size met usual criteria for multivariate analysis (10 patients developing the outcome of interest per variable). All secondary analyses should be considered exploratory. Differences in factors contributing to NEC or in outcomes of NEC in patients with CHD versus those without CHD, which were observed by Pickard et al., 13 could have been missed in this study. It is still unclear why infants with CHD are at an increased risk for NEC. Chronic hypoperfusion of the intestine from alterations in circulation may increase the risk for necrosis in these infants. Alternatively, NEC may be a result of a chronic state of inflammation that can be seen in patients with CHF or cyanosis. In a cohort of infants with CHD receiving prostaglandins between 1997 and 2010, the adjusted odds of NEC increased with single ventricle defects but not with enteral feeding.
14 A retrospective study of neonates with CHD in a cardiac intensive care unit showed that the adjusted odds of NEC increased with the number of red blood cells transfusions. 15 As premature infants with severe CHD are at an increased risk for the development of NEC, strategies to decrease the frequency of NEC in this vulnerable population are needed. If possible, delivering CHD infants prematurely should be avoided. Once delivered, improvements in monitoring of these infants, use of near infrared spectroscopy, judicious transfusion approach and antibiotic use, or alternate feeding strategies could decrease the frequency of NEC. Dewitt et al. reported that lower regional splanchnic oxygen saturations using near infrared spectroscopy were associated with an increased risk for the development of NEC in patients undergoing single ventricle surgical repair. 16 Castillo et al. reported success in reducing the incidence of NEC in infants with hypoplastic left heart with the introduction of a feeding protocol and Dili et al. reported reduced risk for the development of NEC in infants with cyanotic congenital heart disease with the use of probiotics. 17, 18 In this cohort, severe CHD but not mild CHD was independently associated with an increased risk for NEC. Both severe CHD and mild CHD were independently associated with increased mortality before discharge. Increasing GA and BW z-score were independently associated with a decrease in the incidence of NEC and mortality before discharge. The adjusted risk of NEC but not mortality was higher in each smaller BW quartile compared with the largest BW quartile. Additional studies are needed to determine whether the increased risk of NEC in patients with septal defects described by Bain et al. could be mediated by CHF or other risk factors. Further investigation is necessary to more precisely define the etiology of NEC in this population and to evaluate modifiable risk factors for NEC in these infants so that management can be optimized to prevent this complication.
